Xeris Pharmaceuticals Reports Third Quarter 2020 Financial Results and Corporate Highlights

Go back to Xeris Pharmaceuticals Reports Third Quarter 2020 Financial Results and Corporate Highlights
(NASDAQ: XERS) Delayed: 7.20 +0.30 (4.35%)
Previous Close $6.90    52 Week High
Open $6.90    52 Week Low
Day High $7.30    P/E N/A 
Day Low $6.86    EPS
Volume 1,978,998